CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 168 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,003,851
-22.5%
126,6240.0%0.00%
-25.0%
Q2 2023$5,163,727
+9.4%
126,6240.0%0.00%0.0%
Q1 2023$4,719,276
-7.7%
126,624
-13.6%
0.00%0.0%
Q4 2022$5,114,455
-41.8%
146,588
-6.6%
0.00%
-50.0%
Q3 2022$8,786,000
+41.5%
156,997
+30.9%
0.01%
+33.3%
Q2 2022$6,208,000
-42.6%
119,935
-19.3%
0.01%
-25.0%
Q1 2022$10,806,000
-40.5%
148,701
-3.2%
0.01%
-33.3%
Q4 2021$18,160,000
-11.5%
153,586
+0.5%
0.01%
-20.0%
Q3 2021$20,509,000
-11.9%
152,884
+6.3%
0.02%
-11.8%
Q2 2021$23,276,000
+105.5%
143,759
+1.9%
0.02%
+88.9%
Q1 2021$11,324,000
+82.2%
141,102
+23.5%
0.01%
+80.0%
Q4 2020$6,214,000
+175.7%
114,234
+0.8%
0.01%
+150.0%
Q3 2020$2,254,000
+20.9%
113,382
+27.8%
0.00%0.0%
Q2 2020$1,864,000
+93.4%
88,700
+12.6%
0.00%
+100.0%
Q1 2020$964,000
-0.9%
78,800
+18.9%
0.00%0.0%
Q4 2019$973,000
+540.1%
66,300
+481.6%
0.00%
Q3 2019$152,000
-47.8%
11,400
+7.2%
0.00%
Q2 2018$291,00010,6380.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders